The US FDA is responsible for the down-turn in new drug approvals,

Inpharma Weekly ◽

10.2165/00128413-200816460-00006 ◽

2008 ◽

Vol &NA; (1646) ◽

pp. 3

Author(s):

&NA;

Keyword(s):

New Drug ◽

The Us ◽

Drug Approvals ◽

Download Full-text

The US FDA is responsible for the down-turn in new drug approvals,

PharmacoEconomics & Outcomes News ◽

10.2165/00151234-200805570-00027 ◽

2008 ◽

Vol 557 (1) ◽

pp. 10-10

Keyword(s):

New Drug ◽

The Us ◽

Drug Approvals ◽

Download Full-text

Hi-Tech Pharmacal's Abbreviated New Drug Application (ANDA) for fluticasone propionate nasal spray 50??g has been granted final approval by the US FDA.

Inpharma Weekly ◽

10.2165/00128413-200816220-00088 ◽

2008 ◽

Vol &NA; (1622) ◽

pp. 22

Author(s):

&NA;

Keyword(s):

Fluticasone Propionate ◽

Nasal Spray ◽

Drug Application ◽

Final Approval ◽

New Drug ◽

The Us ◽

Us Fda ◽

New Drug Application

Download Full-text

The US FDA is permitting the restricted use of Zelnorm [tegaserod] under a treatment investigational new drug protocol

Reactions Weekly ◽

10.2165/00128415-200711630-00002 ◽

2007 ◽

Vol &NA; (1163) ◽

pp. 2

Author(s):

&NA;

Keyword(s):

New Drug ◽

The Us ◽

Us Fda ◽

Download Full-text

The US FDA has granted tentative approval for Mylan Pharmaceuticals' Abbreviated New Drug Application for delayed-release rabeprazole

Inpharma Weekly ◽

10.2165/00128413-200615220-00050 ◽

2006 ◽

Vol &NA; (1522) ◽

pp. 18

Author(s):

&NA;

Keyword(s):

Drug Application ◽

New Drug ◽

Delayed Release ◽

The Us ◽

Tentative Approval ◽

Us Fda ◽

New Drug Application

Download Full-text

The US FDA has granted tentative approval to Teva Pharmaceutical's Abbreviated New Drug Application (ANDA) for lansoprazole.

Inpharma Weekly ◽

10.2165/00128413-200816230-00071 ◽

2008 ◽

Vol &NA; (1623) ◽

pp. 19

Author(s):

&NA;

Keyword(s):

Drug Application ◽

New Drug ◽

The Us ◽

Tentative Approval ◽

Us Fda ◽

New Drug Application

Download Full-text

Banner Pharmacaps has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for nimodipine 30mg soft gelatin capsules.

Inpharma Weekly ◽

10.2165/00128413-200816230-00057 ◽

2008 ◽

Vol &NA; (1623) ◽

pp. 17 ◽

Author(s):

&NA;

Keyword(s):

Drug Application ◽

Gelatin Capsules ◽

New Drug ◽

Soft Gelatin Capsules ◽

The Us ◽

Us Fda ◽

New Drug Application

Download Full-text

The effect of new drug approvals on HIV mortality in the US, 1987–1998

Economics & Human Biology ◽

10.1016/s1570-677x(02)00031-x ◽

2003 ◽

Vol 1 (2) ◽

pp. 259-266 ◽

Author(s):

Frank R. Lichtenberg

Keyword(s):

New Drug ◽

Hiv Mortality ◽

The Us ◽

Download Full-text

Endo Pharmaceuticals received a "not approvable" letter from the US FDA regarding their supplemental New Drug Application for frovatriptan [Frova]

Inpharma Weekly ◽

10.2165/00128413-200716090-00069 ◽

2007 ◽

Vol &NA; (1609) ◽

pp. 23

Author(s):

&NA;

Keyword(s):

Drug Application ◽

Approvable Letter ◽

New Drug ◽

The Us ◽

Us Fda ◽

New Drug Application

Download Full-text

Teva Pharmaceutical's Abbreviated New Drug Application (ANDA) for pravastatin 80mg tablets has been granted final approval by the US FDA.

Inpharma Weekly ◽

10.2165/00128413-200816220-00090 ◽

2008 ◽

Vol &NA; (1622) ◽

pp. 22

Author(s):

&NA;

Keyword(s):

Drug Application ◽

Final Approval ◽

New Drug ◽

The Us ◽

Us Fda ◽

New Drug Application

Download Full-text

Breast cancer drug approvals by the US FDA from 1949 to 2018

Nature Reviews Drug Discovery ◽

10.1038/d41573-019-00201-w ◽

2019 ◽

Vol 19 (1) ◽

pp. 11-11 ◽

Author(s):

Chandra P. Leo ◽

Cornelia Leo ◽

Thomas D. Szucs

Keyword(s):

Breast Cancer ◽

Cancer Drug ◽

The Us ◽

Drug Approvals ◽

Download Full-text